G01N 2333/085
Picornaviridae
Official title: Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
G01N2333/085 (Picornaviridae) appears on 76 US grants and 130 published applications in this corpus.
Search patents in G01N- Granted patents
- 76
- Published applications
- 130
- Assignees
- 97
- Inventors
- 291
- Latest grant
- 27 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 3 |
| 2004 | 1 | 4 |
| 2005 | 0 | 6 |
| 2006 | 2 | 5 |
| 2007 | 1 | 3 |
| 2008 | 1 | 2 |
| 2009 | 6 | 4 |
| 2010 | 3 | 7 |
| 2011 | 2 | 6 |
| 2012 | 1 | 5 |
| 2013 | 0 | 8 |
| 2014 | 2 | 3 |
| 2015 | 4 | 4 |
| 2016 | 6 | 5 |
| 2017 | 1 | 8 |
| 2018 | 6 | 8 |
| 2019 | 8 | 11 |
| 2020 | 8 | 3 |
| 2021 | 1 | 3 |
| 2022 | 3 | 10 |
| 2023 | 3 | 5 |
| 2024 | 3 | 8 |
| 2025 | 5 | 5 |
| 2026 | 3 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Norovirus-binding peptide27 Jan 2026US 12,535,483 B2Kao Corporation
- Optimized oncolytic viruses and uses thereof13 Jan 2026US 12,521,424 B2Sator Therapeutics
- Exosome-mediated diagnosis of hepatitis virus infections and diseases6 Jan 2026US 12,517,129 B2Morehouse School of Medicine
- Human monoclonal antibodies to enterovirus D689 Sep 2025US 12,410,241 B2Vanderbilt University
- Norovirus-binding peptide5 Aug 2025US 12,378,287 B2Kao Corporation
- Methods, systems, and arrays for tickborne pathogen and disease analysis9 Jul 2026US 2026/0194522 A1Vibrant Holdings, LLC
- Recombinant foot-and-mouth disease type a virus inducing strong adaptive immune response and overcoming interference from maternally-derived antibodies, and foot-and-mouth disease vaccine composition comprising same18 Jun 2026US 2026/0166137 A1Republic of Korea (Animal and Plant Quarantine Agency)
- System and method of identification of a specific alkylamide for the treatment of respiratory virus infections23 Apr 2026US 2026/0110696 A1Sonoran University of Health Sciences
- Biomarkers8 Jan 2026US 2026/0009802 A1Oxford University Innovation Limited
- Recombinant foot-and-mouth disease virus type o for inducing robust adaptive immune response and overcoming maternally-derived antibody interference, and foot-and-mouth disease vaccine composition comprising same20 Nov 2025US 2025/0352635 A1Republic of Korea (Animal and Plant Quarantine Agency)
Most cited
By later US patents
- Indicator cell line for detecting RNA viruses and method therefor30US 5,591,579 AWashington University · 1997
- Monoclonal antibodies for detecting Norwalk virus29US 5,861,241 AUniversity of Massachusetts · 1999
- Indicator cell line for detecting RNA viruses and method therefor12US 5,851,757 AWashington University · 1998
- Method and devices for rapid diagnosis of foot-and-mouth disease12US 7,732,145 B2Princeton Biomeditech Corporation · 2010
- Peptide substrates for detecting virus-specified protease activity11US 4,952,493 AE. I. Du Pont de Nemours and Company · 1990